Review of Experimental Studies to Improve Radiotherapy Response in Bladder Cancer: Comments and Perspectives
Bladder cancer is among the top ten most common cancer types in the world. Around 25% of all cases are muscle-invasive bladder cancer, for which the gold standard treatment in the absence of metastasis is the cystectomy. In recent years, trimodality treatment associating maximal transurethral resect...
Main Authors: | Linda Silina, Fatlinda Maksut, Isabelle Bernard-Pierrot, François Radvanyi, Gilles Créhange, Frédérique Mégnin-Chanet, Pierre Verrelle |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2020-12-01
|
Series: | Cancers |
Subjects: | |
Online Access: | https://www.mdpi.com/2072-6694/13/1/87 |
Similar Items
-
Tyro3 Targeting as a Radiosensitizing Strategy in Bladder Cancer through Cell Cycle Dysregulation
by: Linda Silina, et al.
Published: (2022-08-01) -
Radiotherapy and olaparib in combination for carcinoma of the oesophagus: A phase I study
by: Hamid Sheikh, et al.
Published: (2023-05-01) -
Oncologic Impact and Safety of Pre-Operative Radiotherapy in Localized Prostate and Bladder Cancer: A Comprehensive Review from the Cancerology Committee of the Association Française d’Urologie
by: Paul Sargos, et al.
Published: (2021-12-01) -
Adaptation Time as a Determinant of the Dosimetric Effectiveness of Online Adaptive Radiotherapy for Bladder Cancer
by: Aymane Khouya, et al.
Published: (2023-11-01) -
Feasibility and Impact of Immunohistochemistry-based Molecular Subtyping for Muscle-invasive Bladder Cancer in Patients Treated with Radiation-based Therapy
by: Charles Hesswani, et al.
Published: (2023-11-01)